MedPath

Laminaria Tents Versus Vaginal Prostaglandin in Cervical Ripening

Not Applicable
Completed
Conditions
Labor Onset and Length Abnormalities
Interventions
Device: Laminaria
Drug: Vaginal prostaglandin
Registration Number
NCT06151925
Lead Sponsor
Ain Shams University
Brief Summary

Mechanical methods used for induction of labor received a great attention nowadays due to the serious side effects of the pharmacological methods. Hygroscopic dilators are considered important subtype of these mechanical methods. One of them is Laminaria which is a synthetic type of sea algae that induces cervical dilation by absorbing water from the cervix and gradually increasing in thickness. The current study will compare the effectiveness and safety of laminiria and vaginal prostaglandins in induction of labor in women with unfavorable cervix.

Detailed Description

A new method for induction of labor to be studied

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Pregnant women with:

    • Age 18-45 years.
    • Live fetus with cephalic presentation.
    • Normal non-stress test with reassuring features (baseline heart rate 110-160 beats/min, baseline variability 5-25 beats/minute, and no decelerations) (National Institute for Health and Clinical Excellence 2017).
    • Gestational age of 37 weeks or more (Middleton et al. 2020).
    • Fetal weight less than 4 kilograms.
    • Bishop score less than 6 (Navve et al. 2017).
    • No labor pains.
    • No contraindications for vaginal delivery
Exclusion Criteria
  • o Presence of fetal distress.

    • Presence of thick meconium-stained amniotic fluid
    • Presence of fever, chorioamnionitis, or vaginal bleeding before intervention.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laminaria tents groupLaminariaLaminaria tent used to be inserted in cervix and left for 6-12 hours
Laminaria tents groupVaginal prostaglandinLaminaria tent used to be inserted in cervix and left for 6-12 hours
vaginal prostaglandin groupLaminariaMisoprostol 25 mcg inserted for one or multiple doses
vaginal prostaglandin groupVaginal prostaglandinMisoprostol 25 mcg inserted for one or multiple doses
Primary Outcome Measures
NameTimeMethod
o Bishop Score and cervical dilatation2 YEARS

Tool to assess cervical status

Secondary Outcome Measures
NameTimeMethod
o Induction time to active phase of labor.2 YEARS

Time between start and 5cm dilatation

o Induction time to delivery time.2 YEARS

Time between start to delivery

Trial Locations

Locations (1)

Ain Shams University Faculty Of Medicine

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath